PREVENTION OF PREECLAMPSIA WITH LOW-DOSE ASPIRIN – A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE MAIN RANDOMIZED CONTROLLED TRIALS

Lenfant, 2001, Working group report on high blood pressure in pregnancy. J Clin Hypertens, (Greenwich), 3, 75, 10.1111/j.1524-6175.2001.00458.x

1988, Geographic variation in the incidence of hypertension in pregnancy, Am J Obstet Gynecol, 158, 80, 10.1016/0002-9378(88)90782-X

Dulcy, 1992, Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and Caribbean, Am J Obstet Gynecol, 99, 546

Parisi, 1986, Arachidonic acid metabolites and the regulation of placental and other vascular tone during pregnancy, Semin Perinatol, 10, 288

Walsh, 1986, The role of arachidonic acid metabolites in preeclampsia, Semin Perinatol, 10, 334

Bussolino, 1980, Maternal vascular prostacyclin activity in pre-eclampsia, Lancet, 2, 702, 10.1016/S0140-6736(80)92746-4

Duley, 2001, Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review, BMJ, 322, 329, 10.1136/bmj.322.7282.329

2000, Cochrane controlled trials register

Longo, 2003, Preeclampsia and eclampsia revisited, South Med J, 96, 891, 10.1097/01.SMJ.0000084385.85123.08

Roberts, 2003, Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy, Hypertens Pregnancy, 22, 109, 10.1081/PRG-120016792

Hauth, 1993, Low-dose aspirin therapy to prevent preeclampsia, Am J Obstet Gynecol, 168, 1083, 10.1016/0002-9378(93)90351-I

Sibai, 1993, Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, N Engl J Med, 329, 1213, 10.1056/NEJM199310213291701

Rotchell, 1998, Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications, Br J Obstet Gynaecol, 105, 286, 10.1111/j.1471-0528.1998.tb10088.x

Golding, 1998, A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group, Br J Obstet Gynaecol, 105, 293, 10.1111/j.1471-0528.1998.tb10089.x

Subtil, 2003, Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1), BJOG, 110, 475

Beaufils, 1985, Prevention of preeclampsia by early antiplatelet therapy, Lancet, 1, 840, 10.1016/S0140-6736(85)92207-X

Benigni, 1989, Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension, N Engl J Med, 321, 357, 10.1056/NEJM198908103210604

Porreco, 1993, Low-dose aspirin and hypertension in pregnancy, Lancet, 341, 312, 10.1016/0140-6736(93)92672-G

Wiinikka, 1993, Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn, Br J Obstet Gynaecol, 100, 809, 10.1111/j.1471-0528.1993.tb14304.x

1994, CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group, Lancet, 343, 619, 10.1016/S0140-6736(94)92633-6

Wenstrom, 1995, The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels, Am J Obstet Gynecol, 173, 1292, 10.1016/0002-9378(95)91373-4

1996, ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group, Br J Obstet Gynaecol, 103, 39, 10.1111/j.1471-0528.1996.tb09513.x

Caritis, 1998, Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, N Engl J Med, 338, 701, 10.1056/NEJM199803123381101

McParland, 1990, Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension, Lancet, 335, 1552, 10.1016/0140-6736(90)91377-M

Morris, 1996, A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow, Obstet Gynecol, 87, 74, 10.1016/0029-7844(95)00340-1

Bower, 1996, Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin, Br J Obstet Gynaecol, 103, 625, 10.1111/j.1471-0528.1996.tb09829.x

Zimmermann, 1997, Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnancies at high risk for pre-eclampsia and/or intrauterine growth retardation: comparison and correlation between different Doppler parameters, Ultrasound Obstet Gynecol, 9, 330, 10.1046/j.1469-0705.1997.09050330.x

Harrington, 2000, A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks, Ultrasound Obstet Gynecol, 15, 13, 10.1046/j.1469-0705.2000.00002.x

Subtil, 2003, Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 2), BJOG, 110, 485

Schiff, 1989, The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies, N Engl J Med, 321, 351, 10.1056/NEJM198908103210603

Wallenburg, 1986, Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae, Lancet, 1, 1, 10.1016/S0140-6736(86)91891-X

Yu, 2003, Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks’ gestation, Ultrasound Obstet Gynecol, 22, 233, 10.1002/uog.218

Moher, 1999, Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses, Lancet, 354, 1896, 10.1016/S0140-6736(99)04149-5

Wallenburg, 2001, Prevention of pre-eclampsia: status and perspectives 2000, Eur J Obstet Gynecol Reprod Biol, 94, 13, 10.1016/S0301-2115(00)00303-1

Leitich, 1997, A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation, Br J Obstet Gynaecol, 104, 450, 10.1111/j.1471-0528.1997.tb11497.x

Dumont, 1999, Effect of aspirin in pregnant women is dependent on increase in bleeding time, Am J Obstet Gynecol, 180, 135, 10.1016/S0002-9378(99)70163-8

Caritis, 1998, Predictors of pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, Am J Obstet Gynecol, 179, 946, 10.1016/S0002-9378(98)70194-2

Sibai, 2000, Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, Am J Obstet Gynecol, 182, 364, 10.1016/S0002-9378(00)70225-0

Odegard, 2000, Risk factors and clinical manifestations of pre-eclampsia, BJOG, 107, 1410, 10.1111/j.1471-0528.2000.tb11657.x

Sibai, 1998, Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, N Engl J Med, 339, 667, 10.1056/NEJM199809033391004

Heyborne, 2000, Preeclampsia prevention: lessons from the low-dose aspirin therapy trials, Am J Obstet Gynecol, 183, 523, 10.1067/mob.2000.106757

Chien, 2000, How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview, BJOG, 107, 196, 10.1111/j.1471-0528.2000.tb11690.x

Coomarasamy, 2001, Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis, Obstet Gynecol, 98, 861

Carp, 2004, Antiphospholipid syndrome in pregnancy, Curr Opin Obstet Gynecol, 16, 129, 10.1097/00001703-200404000-00006

Derksen, 2004, Management of the obstetric antiphospholipid syndrome, Arthritis Rheum, 50, 1028, 10.1002/art.20105

Dunoyer-Geindre, 2004, Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies, J Thromb Haemost, 2, 1176, 10.1111/j.1538-7836.2004.00801.x

Greer, 2003, Thrombophilia: implications for pregnancy outcome, Thromb Res, 109, 73, 10.1016/S0049-3848(03)00095-1

Haram, 2003, Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome, Acta Obstet Gynecol Scand, 82, 679, 10.1034/j.1600-0412.2003.00181.x

Heilmann, 2003, Antiphospholipid syndrome in obstetrics, Clin Appl Thromb Hemost, 9, 143, 10.1177/107602960300900209

Kurum, 2003, A case of primary antiphospholipid syndrome who developed acute myocardial infarction followed by early-onset pre-eclampsia, Clin Rheumatol, 22, 160, 10.1007/s10067-002-0674-1

Mackworth-Young, 2004, Antiphospholipid syndrome: multiple mechanisms, Clin Exp Immunol, 136, 393, 10.1111/j.1365-2249.2004.02497.x

Roberts, 2003, Acute renal failure complicating HELLP syndrome, SLE and anti-phospholipid syndrome: successful outcome using plasma exchange therapy, Lupus, 12, 251, 10.1191/0961203303lu378xx